This webinar presents the methodology and feasibility of repeated household and facility phone interviews to measure medicines availability and price. Phone interviews have become increasingly relevant, particularly during the pandemic where physical distancing is critical to keep participants and data collectors safe.
We will use the example of the evaluation of Novartis Access, a price scheme to promote the availability and affordability of non-communicable medicines, in Kenya as an example to illustrate how phone interviews are used to collect and validate data.
- Paul Ashigbie – BPharm, MPH, DrPH (USA). A pharmacist and public health professional who has worked for more than a decade to promote policies and practices that support access to quality and affordable medicines in low resource settings. Paul attended the Kwame Nkrumah University of Science and Technology and started his career as a practicing pharmacist in Ghana. He later joined Boston University School of Public Health where he collaborated with the World Health Organization on various health systems research projects. He also developed Boston University’s “Global Health Practicum” in Ghana and directed field-based studies focused on drug access for underserved populations. Paul currently manages Global Health programs at the Novartis Institutes for BioMedical Research, working to improve scientific capabilities and access to innovative medicines in developing countries.
- John Mboya – BSc, MSc candidate (Kenya). Before joining IPA John worked as a laboratory technologist intern and locum at the Agakhan hospital Kisumu pathology department and KEMRI- CDC HIV research laboratories for 2 years. Since 2009, John has worked with IPA as a field manager and research associate. He has experience in field team management, data management having worked in multiple in multiple research projects such as HIV/AIDS & education impact evaluation study, health care access and equity impact evaluation study, WASH +nutrition impact evaluation study, WASH and helminthes & E.coli study and Evaluation of Novartis Access study.
- Zana Kiragu – MPharm, MPH (Kenya/USA). a Kenyan pharmacist and public health professional working in the access to medicines space. She is currently a Research Fellow at Boston University School of Public Health, and also pursuing Doctor of Public Health (DrPH) in Leadership, Management and Policy at the university. She received her Masters of Public Health at Johns Hopkins Bloomberg School of Public Health in 2019, and her Bachelors and Master of Pharmacy at the University of Manchester in 2015. She has pharmacy practice experience in industrial, clinical and retail settings in both the UK and Kenya. She is passionate about health systems strengthening and is committed to learning.
Moderated by Veronika Wirtz, co-chair, and Sam Orubu, coordinator of the Medicines in Health Systems Thematic Working Group.